Patent · US Active

Derivatives of relebactam and uses thereof

US11180500B2 · kind B2 · utility

0Cited by

12References

14Claims

0Family size

Assignee

Arixa Pharmaceuticals, Inc. · US

Inventors

Eric M. Gordon · Pennington, US
Matthew Duncton · San Francisco, US
John Freund · Atherton, US

Key dates

Filing date	Oct 1, 2019
Grant date	Nov 23, 2021
Priority date	—
Expiry date	Oct 1, 2039

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K9/0053
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Derivatives of relebactam, therapeutic methods of using the derivatives of relebactam, particularly in combination with β-lactam antibiotics and pharmaceutical compositions thereof are disclosed. The derivatives of relebactam are suitable for oral administration.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.